Previous 10 | Next 10 |
home / stock / bayry / bayry news
Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven rebound in value stocks. My dividend income amounted to $3...
This article initiates coverage of Siemens Aktiengesellschaft often called Siemens. Siemens is a leading player in its industry and is a diversified defensive way to gain exposure to global infrastructure stimulus measures. The share price has risen 16% over the past year and as s...
CureVac (CVAC) has struck an alliance with Bayer (BAYRY) to get global support in seeking approval for its experimental COVID-19 vaccine and for distribution, Bild reports.Under the deal, Bayer will provide access to international pharmaceutical markets, as well as its global supply chain and...
This article initiates coverage of Bayer Aktiengesellschaft often called Bayer AG or just Bayer. Bayer has significant short-term headwinds which have depressed the stock price. It has high levels of debt and continues to have litigation pressures that will likely cost more than &...
In view of the overheated markets, it is worthwhile to take a look at the not so well-trodden paths. However, investors are facing a dilemma. There are a lot of great companies, but only a small number of good investments. In this article, I will name a few European companies that...
Trading Penny Stocks On The OTC VS Nasdaq/NYSE If you’re looking for penny stocks to buy , you’re likely going to find plenty to choose from. In the stock market today, there are, however, a few things to keep in mind. First and foremost, are you able to buy all penn...
November was characterized by a contested U.S. Presidential Election and a series of surprisingly positive and encouraging COVID-19 vaccine news. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven re...
Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies. After unprofitable commercialization of the high oleic soybean oil, CLXT is shifting strategy to focus solely on seed produc...
The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into December 2020. Rather than offering some sort of collective "list" that could potentially be hard to offer a clear overview, I go sector by sector and present 1-2 alterna...
Sigilon Therapeutics has filed proposed terms for its $101 million U.S. IPO. The firm is advancing programs to treat blood, lysosomal storage and other diseases. SGTX has produced a positive initial result with its first trial patient, has a strong collaboration relationship with ...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...